难治性肺结核咯血23例临床诊断与治疗分析

Analysis of the clinical diagnosis and treatment on 23 cases of refractory pulmonary tuberculosis hemoptysis

目的:探讨难治性肺结核咯血的临床诊疗方法。方法:2013年1月-2014年7月收治难治性肺结核咯血患者46例,按随机法将其分成试验组和对照组,各23例,均给予常规治疗,在此基础上再对试验组病例应用莫西沙星治疗,对比疗效。结果:试验组难治性肺结核咯血治疗效果优于对照组,试验组临床总有效率91.3%,平均止血时间(2.04±0.36)d,与对照组相比,差异有统计学意义(P<0.05)。结论:莫西沙星治疗难治性肺结核咯血,疗效满意,安全性高,值得临床进一步应用、推广。

Objective:To investigate the clinical diagnosis and treatment of refractory pulmonary tuberculosis hemoptysis.Methods:46 patients with refractory pulmonary tuberculosis hemoptysis were selected from January 2013 to July 2014.They were divided into the experiment group and the control group according to the coin method with 23 cases in each group,and they were given conventional treatment.Based on this treatment,the experimental group applicated moxifloxacin,then we compared the curative effect between two groups.Results:The treatment effect of experimental group was better than that of the control group.The clinical total effectiveness of the experiment group was 91.3%,and the average hemostasis time was (2.04±0.36) d.Compared with the control group,the difference was statistically significant(P<0.05).Conclusion:Moxifloxacin in the treatment of refractory pulmonary tuberculosis hemoptysis has satisfactory curative effect and high safety,so it is worthy of further clinical application and popularization.